Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Kaj Blennow

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Brain

Physiology

Procedures

Phenomena

Phosphorylation

Genes & Molecular Sequences

Alleles

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gavhed Désirée; Akefeldt Selma Olsson; Osterlundh Gustaf; Laurencikas Evaldas; Hjorth Lars; Blennow Kaj; Rosengren Lars; Henter Jan-Inge
Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
Mattsson Niklas; Blennow Kaj; Zetterberg Henrik
CSF biomarkers: pinpointing Alzheimer pathogenesis.
Reynolds Chandra A; Hong Mun-Gwan; Eriksson Ulrika K; Blennow Kaj; Bennet Anna M; Johansson Boo; Malmberg Bo; Berg Stig; Wiklund Fredrik; Gatz Margaret; Pedersen Nancy L; Prince Jonathan A
A survey of ABCA1 sequence variation confirms association with dementia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kaj Blennow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gavhed Désirée; Akefeldt Selma Olsson; Osterlundh Gustaf; Laurencikas Evaldas; Hjorth Lars; Blennow Kaj; Rosengren Lars; Henter Jan-Inge
Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
Pediatric blood & cancer 2009;53(7):1264-70.
2009: Mattsson Niklas; Blennow Kaj; Zetterberg Henrik
CSF biomarkers: pinpointing Alzheimer pathogenesis.
Annals of the New York Academy of Sciences 2009;1180():28-35.
2009: Reynolds Chandra A; Hong Mun-Gwan; Eriksson Ulrika K; Blennow Kaj; Bennet Anna M; Johansson Boo; Malmberg Bo; Berg Stig; Wiklund Fredrik; Gatz Margaret; Pedersen Nancy L; Prince Jonathan A
A survey of ABCA1 sequence variation confirms association with dementia.
Human mutation 2009;30(9):1348-54.
2009: Buerger Katharina; Frisoni Giovanni; Uspenskaya Olga; Ewers Michael; Zetterberg Henrik; Geroldi Cristina; Binetti Giuliano; Johannsen Peter; Rossini Paolo Maria; Wahlund Lars-Olof; Vellas Bruno; Blennow Kaj; Hampel Harald
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
Experimental gerontology 2009;44(9):579-85.
2009: Philipson Ola; Hammarström Per; Nilsson K Peter R; Portelius Erik; Olofsson Tommie; Ingelsson Martin; Hyman Bradley T; Blennow Kaj; Lannfelt Lars; Kalimo Hannu; Nilsson Lars N G
A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
Neurobiology of aging 2009;30(9):1393-405.
2009: Zetterberg Henrik; Tanriverdi Fatih; Unluhizarci Kursad; Selcuklu Ahmet; Kelestimur Fahrettin; Blennow Kaj
Sustained release of neuron-specific enolase to serum in amateur boxers.
Brain injury : [BI] 2009;23(9):723-6.
2009: Mattsson Niklas; Zetterberg Henrik; Hansson Oskar; Andreasen Niels; Parnetti Lucilla; Jonsson Michael; Herukka Sanna-Kaisa; van der Flier Wiesje M; Blankenstein Marinus A; Ewers Michael; Rich Kenneth; Kaiser Elmar; Verbeek Marcel; Tsolaki Magda; Mulugeta Ezra; Rosén Erik; Aarsland Dag; Visser Pieter Jelle; Schröder Johannes; Marcusson Jan; de Leon Mony; Hampel Harald; Scheltens Philip; Pirttilä Tuula; Wallin Anders; Jönhagen Maria Eriksdotter; Minthon Lennart; Winblad Bengt; Blennow Kaj
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
JAMA : the journal of the American Medical Association 2009;302(4):385-93.
2009: Kwiecinski Jakub; Klak Marcin; Trysberg Estelle; Blennow Kaj; Tarkowski Andrej; Jin Tao
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Arthritis and rheumatism 2009;60(7):2094-101.
2009: Visser Pieter Jelle; Verhey Frans; Knol Dirk L; Scheltens Philip; Wahlund Lars-Olof; Freund-Levi Yvonne; Tsolaki Magda; Minthon Lennart; Wallin Asa K; Hampel Harald; Bürger Katharina; Pirttila Tuula; Soininen Hilkka; Rikkert Marcel Olde; Verbeek Marcel M; Spiru Luiza; Blennow Kaj
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Lancet neurology 2009;8(7):619-27.
2009: Zhang Y; Londos E; Minthon L; Wattmo C; Blennow K; Liu H J; Bronge L; Aspelin P; Wahlund L-O
Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes.
Acta radiologica (Stockholm, Sweden : 1987) 2009;50(6):674-81.
2009: Berggren Ulf; Fahlke Claudia; Berglund Kristina J; Blennow Kaj; Zetterberg Henrik; Balldin Jan
Thrombocytopenia in early alcohol withdrawal is associated with development of delirium tremens or seizures.
Alcohol and alcoholism (Oxford, Oxfordshire) 2009;44(4):382-6.
2009: Strozyk Dorothea; Launer Lenore J; Adlard Paul A; Cherny Robert A; Tsatsanis Andrew; Volitakis Irene; Blennow Kaj; Petrovitch Helen; White Lon R; Bush Ashley I
Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.
Neurobiology of aging 2009;30(7):1069-77.
2009: Marklund Niklas; Blennow Kaj; Zetterberg Henrik; Ronne-Engström Elisabeth; Enblad Per; Hillered Lars
Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury.
Journal of neurosurgery 2009;110(6):1227-37.
2009: Wallin A K; Hansson O; Blennow K; Londos E; Minthon L
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
International journal of geriatric psychiatry 2009;24(6):638-47.
2009: Zetterberg Henrik; Andreasen Niels; Blennow Kaj
[Biomarkers in cerebrospinal fluid and blood in memory complaints]
Läkartidningen 2009;106(20):1386-9.
2009: Zetterberg Henrik; Andreasson Ulf; Blennow Kaj
CSF antithrombin III and disruption of the blood-brain barrier.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2302-3; author reply 2303-4.
2009: Glodzik-Sobanska Lidia; Pirraglia Elizabeth; Brys Miroslaw; de Santi Susan; Mosconi Lisa; Rich Kenneth E; Switalski Remigiusz; Saint Louis Leslie; Sadowski Martin J; Martiniuk Frank; Mehta Pankaj; Pratico Domenico; Zinkowski Raymond P; Blennow Kaj; de Leon Mony J
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.
Neurobiology of aging 2009;30(5):672-81.
2009: Brys Miroslaw; Pirraglia Elizabeth; Rich Kenneth; Rolstad Sindre; Mosconi Lisa; Switalski Remigiusz; Glodzik-Sobanska Lidia; De Santi Susan; Zinkowski Ray; Mehta Pankaj; Pratico Domenico; Saint Louis Leslie A; Wallin Anders; Blennow Kaj; de Leon Mony J
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.
Neurobiology of aging 2009;30(5):682-90.
2009: Shaw Leslie M; Vanderstichele Hugo; Knapik-Czajka Malgorzata; Clark Christopher M; Aisen Paul S; Petersen Ronald C; Blennow Kaj; Soares Holly; Simon Adam; Lewczuk Piotr; Dean Robert; Siemers Eric; Potter William; Lee Virginia M-Y; Trojanowski John Q;
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
Annals of neurology 2009;65(4):403-13.
2009: Mattsson N; Axelsson M; Haghighi S; Malmeström C; Wu G; Anckarsäter R; Sankaranarayanan S; Andreasson U; Fredrikson S; Gundersen A; Johnsen L; Fladby T; Tarkowski A; Trysberg E; Wallin A; Anckarsäter H; Lycke J; Andersen O; Simon A J; Blennow K; Zetterberg H
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(4):448-54.
2009: Mattsson N; Yaong M; Rosengren L; Blennow K; Månsson J-E; Andersen O; Zetterberg H; Haghighi S; Zho I; Pratico D
Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis.
Journal of internal medicine 2009;265(4):459-64.
2009: Sjölander Annica; Minthon Lennart; Bogdanovic Nenad; Wallin Anders; Zetterberg Henrik; Blennow Kaj
The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
Neurobiology of aging 2009;30(4):666-8.
2009: Hansson Sara F; Andréasson Ulf; Wall Mariann; Skoog Ingmar; Andreasen Niels; Wallin Anders; Zetterberg Henrik; Blennow Kaj
Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
Journal of Alzheimer's disease : JAD 2009;16(2):389-97.
2009: Brys Miroslaw; Glodzik Lidia; Mosconi Lisa; Switalski Remigiusz; De Santi Susan; Pirraglia Elizabeth; Rich Kenneth; Kim Byeong C; Mehta Pankaj; Zinkowski Ray; Pratico Domenico; Wallin Anders; Zetterberg Henrik; Tsui Wai H; Rusinek Henry; Blennow Kaj; de Leon Mony J
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;16(2):351-62.
2009: Ohrfelt Annika; Grognet Pierre; Andreasen Niels; Wallin Anders; Vanmechelen Eugeen; Blennow Kaj; Zetterberg Henrik
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Neuroscience letters 2009;450(3):332-5.
2009: Hansson Oskar; Buchhave Peder; Zetterberg Henrik; Blennow Kaj; Minthon Lennart; Warkentin Siegbert
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
Neurobiology of aging 2009;30(2):165-73.
2009: Wasling Pontus; Daborg Jonny; Riebe Ilse; Andersson My; Portelius Erik; Blennow Kaj; Hanse Eric; Zetterberg Henrik
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;16(1):1-14.
2009: Kalm Marie; Fukuda Aya; Fukuda Hirotsugu; Ohrfelt Annika; Lannering Birgitta; Björk-Eriksson Thomas; Blennow Kaj; Márky Ildikó; Blomgren Klas
Transient inflammation in neurogenic regions after irradiation of the developing brain.
Radiation research 2009;171(1):66-76.
2009: Zetterberg Henrik; Alexander David M; Spandidos Demetrios A; Blennow Kaj
Additional evidence for antagonistic pleiotropic effects of APOE.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(1):75.
2009: Gerhardsson Lars; Blennow Kaj; Lundh Thomas; Londos Elisabet; Minthon Lennart
Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2009;28(1):88-94.
2009: Blennow Kaj; Zetterberg Henrik
Cerebrospinal fluid biomarkers for Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;18(2):413-7.
2009: Buchhave Peder; Blennow Kaj; Zetterberg Henrik; Stomrud Erik; Londos Elisabet; Andreasen Niels; Minthon Lennart; Hansson Oskar
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
PloS one 2009;4(7):e6294.
2009: Blom Elin S; Giedraitis Vilmantas; Zetterberg Henrik; Fukumoto Hiroaki; Blennow Kaj; Hyman Bradley T; Irizarry Michael C; Wahlund Lars-Olof; Lannfelt Lars; Ingelsson Martin
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
Dementia and geriatric cognitive disorders 2009;27(5):458-64.
2009: Westman-Brinkmalm Ann; Ruetschi Ulla; Portelius Erik; Andreasson Ulf; Brinkmalm Gunnar; Karlsson Gosta; Hansson Sara; Zetterberg Henrik; Blennow Kaj
Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases.
Frontiers in bioscience : a journal and virtual library 2009;14():1793-806.
2009: Portelius Erik; Brinkmalm Gunnar; Tran Ai Jun; Zetterberg Henrik; Westman-Brinkmalm Ann; Blennow Kaj
Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
Neuro-degenerative diseases 2009;6(3):87-94.
2008: Landgren Sara; Jerlhag Elisabet; Zetterberg Henrik; Gonzalez-Quintela Arturo; Campos Joaquin; Olofsson Ulrica; Nilsson Staffan; Blennow Kaj; Engel Jörgen A
Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass.
Alcoholism, clinical and experimental research 2008;32(12):2054-61.
2008: Ost M; Nylén K; Csajbok L; Blennow K; Rosengren L; Nellgård B
Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury.
Acta anaesthesiologica Scandinavica 2008;52(10):1364-9.
2008: Lee Jin-Moo; Blennow Kaj; Andreasen Niels; Laterza Omar; Modur Vijay; Olander Jitka; Gao Feng; Ohlendorf Matt; Ladenson Jack H
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.
Clinical chemistry 2008;54(10):1617-23.
2008: Zetterberg Henrik; Jacobsson Johan; Rosengren Lars; Blennow Kaj; Andersen Peter M
Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.
Journal of the neurological sciences 2008;273(1-2):67-9.
2008: Andersson Christin; Blennow Kaj; Almkvist Ove; Andreasen Niels; Engfeldt Peter; Johansson Sven-Erik; Lindau Maria; Eriksdotter-Jönhagen Maria
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia.
Neurobiology of aging 2008;29(10):1466-73.
2008: Lannfelt Lars; Blennow Kaj; Zetterberg Henrik; Batsman Stellan; Ames David; Harrison John; Masters Colin L; Targum Steve; Bush Ashley I; Murdoch Ross; Wilson Janet; Ritchie Craig W;
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
Lancet neurology 2008;7(9):779-86.
2008: Winblad S; Månsson J E; Blennow K; Jensen C; Samuelsson L; Lindberg C
Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(9):947-52.
2008: Zetterberg Madeleine; Landgren Sara; Andersson Malin E; Palmér Mona Seibt; Gustafson Deborah R; Skoog Ingmar; Minthon Lennart; Thelle Dag S; Wallin Anders; Bogdanovic Nenad; Andreasen Niels; Blennow Kaj; Zetterberg Henrik
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(6):720-6.
2008: Zetterberg Henrik; Andreasson Ulf; Hansson Oskar; Wu Guoxin; Sankaranarayanan Sethu; Andersson Malin E; Buchhave Peder; Londos Elisabet; Umek Robert M; Minthon Lennart; Simon Adam J; Blennow Kaj
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
Archives of neurology 2008;65(8):1102-7.
2008: Hong Mun-Gwan; Reynolds Chandra; Gatz Margaret; Johansson Boo; Palmer Jennifer C; Gu Harvest F; Blennow Kaj; Kehoe Patrick G; de Faire Ulf; Pedersen Nancy L; Prince Jonathan A
Evidence that the gene encoding insulin degrading enzyme influences human lifespan.
Human molecular genetics 2008;17(15):2370-8.
2008: Frisoni Giovanni B; Henneman Wouter J P; Weiner Michael W; Scheltens Philip; Vellas Bruno; Reynish Emma; Hudecova Jaroslava; Hampel Harald; Burger Katharina; Blennow Kaj; Waldemar Gunhild; Johannsen Peter; Wahlund Lars-Olof; Zito Giancarlo; Rossini Paolo M; Winblad Bengt; Barkhof Frederik;
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(4):255-64.
2008: Nordlund Arto; Rolstad Sindre; Klang Ola; Lind Karin; Pedersen Mona; Blennow Kaj; Edman Ake; Hansen Stefan; Wallin Anders
Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
Journal of the International Neuropsychological Society : JINS 2008;14(4):582-90.
2008: Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
Clinical proteomics in neurodegenerative disorders.
Acta neurologica Scandinavica 2008;118(1):1-11.
2008: Simonsen A H; McGuire J; Podust V N; Davies H; Minthon L; Skoog I; Andreasen N; Wallin A; Waldemar G; Blennow K
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.
Neurobiology of aging 2008;29(7):961-8.
2008: Corder Elizabeth H; Blennow Kaj; Prince Jonathan A
Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci.
Rejuvenation research 2008;11(3):667-79.
2008: Portelius Erik; Hansson Sara F; Tran Ai Jun; Zetterberg Henrik; Grognet Pierre; Vanmechelen Eugeen; Höglund Kina; Brinkmalm Gunnar; Westman-Brinkmalm Ann; Nordhoff Eckhard; Blennow Kaj; Gobom Johan
Characterization of tau in cerebrospinal fluid using mass spectrometry.
Journal of proteome research 2008;7(5):2114-20.
2008: Ewers Michael; Zhong Zhenyu; Bürger Katharina; Wallin Anders; Blennow Kaj; Teipel Stefan J; Shen Yong; Hampel Harald
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Brain : a journal of neurology 2008;131(Pt 5):1252-8.
2008: Kadir Ahmadul; Andreasen Niels; Almkvist Ove; Wall Anders; Forsberg Anton; Engler Henry; Hagman Göran; Lärksäter Marie; Winblad Bengt; Zetterberg Henrik; Blennow Kaj; Långström Bengt; Nordberg Agneta
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.
Annals of neurology 2008;63(5):621-31.
2008: Portelius Erik; Zetterberg Henrik; Gobom Johan; Andreasson Ulf; Blennow Kaj
Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.
Expert review of proteomics 2008;5(2):225-37.
2008: Klyubin Igor; Betts Vicki; Welzel Alfred T; Blennow Kaj; Zetterberg Henrik; Wallin Anders; Lemere Cynthia A; Cullen William K; Peng Ying; Wisniewski Thomas; Selkoe Dennis J; Anwyl Roger; Walsh Dominic M; Rowan Michael J
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(16):4231-7.
2008: Nylén K; Ost M; Csajbok L Z; Nilsson I; Hall C; Blennow K; Nellgård B; Rosengren L
Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
Acta neurochirurgica 2008;150(3):221-7; discussion 227.
2008: Hampel Harald; Bürger Katharina; Teipel Stefan J; Bokde Arun L W; Zetterberg Henrik; Blennow Kaj
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(1):38-48.
2008: Zetterberg Henrik; Blennow Kaj
Biological CSF Markers of Alzheimer's Disease.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2008;89():261-8.
2008: Buchhave Peder; Stomrud Erik; Warkentin Siegbert; Blennow Kaj; Minthon Lennart; Hansson Oskar
Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease.
Dementia and geriatric cognitive disorders 2008;25(6):544-52.
2008: Tullberg Mats; Blennow Kaj; Månsson Jan-Eric; Fredman Pam; Tisell Magnus; Wikkelsö Carsten
Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus.
Cerebrospinal fluid research 2008;5():9.
2008: Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Neuro-degenerative diseases 2008;5(5):268-76.
2008: Anckarsäter R; Zetterberg H; Månsson J-E; Blennow K; Anckarsäter H
Non-neurological surgery results in a neurochemical stress response.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(3):397-9.
2007: Ewers M; Buerger K; Teipel S J; Scheltens P; Schröder J; Zinkowski R P; Bouwman F H; Schönknecht P; Schoonenboom N S M; Andreasen N; Wallin A; DeBernardis J F; Kerkman D J; Heindl B; Blennow K; Hampel H
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.
Neurology 2007;69(24):2205-12.
2007: Gustafson D R; Karlsson C; Skoog I; Rosengren L; Lissner L; Blennow K
Mid-life adiposity factors relate to blood-brain barrier integrity in late life.
Journal of internal medicine 2007;262(6):643-50.
2007: Mattsson Niklas; Rüetschi Ulla; Podust Vladimir N; Stridsberg Mats; Li Susann; Andersen Oluf; Haghighi Sara; Blennow Kaj; Zetterberg Henrik
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis.
Journal of neurochemistry 2007;103(5):1932-9.
2007: Zetterberg H; Jacobsson J; Rosengren L; Blennow K; Andersen P M
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(12):1329-33.
2007: Zetterberg Henrik; Pedersen Mona; Lind Karin; Svensson Maria; Rolstad Sindre; Eckerström Carl; Syversen Steinar; Mattsson Ulla-Britt; Ysander Christina; Mattsson Niklas; Nordlund Arto; Vanderstichele Hugo; Vanmechelen Eugeen; Jonsson Michael; Edman Ake; Blennow Kaj; Wallin Anders
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.
Journal of Alzheimer's disease : JAD 2007;12(3):255-60.
2007: Ray Sandip; Britschgi Markus; Herbert Charles; Takeda-Uchimura Yoshiko; Boxer Adam; Blennow Kaj; Friedman Leah F; Galasko Douglas R; Jutel Marek; Karydas Anna; Kaye Jeffrey A; Leszek Jerzy; Miller Bruce L; Minthon Lennart; Quinn Joseph F; Rabinovici Gil D; Robinson William H; Sabbagh Marwan N; So Yuen T; Sparks D Larry; Tabaton Massimo; Tinklenberg Jared; Yesavage Jerome A; Tibshirani Robert; Wyss-Coray Tony
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.
Nature medicine 2007;13(11):1359-62.
2007: Portelius Erik; Tran Ai Jun; Andreasson Ulf; Persson Rita; Brinkmalm Gunnar; Zetterberg Henrik; Blennow Kaj; Westman-Brinkmalm Ann
Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.
Journal of proteome research 2007;6(11):4433-9.
2007: Agren-Wilsson A; Lekman A; Sjöberg W; Rosengren L; Blennow K; Bergenheim A T; Malm J
CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
Acta neurologica Scandinavica 2007;116(5):333-9.
2007: Gudmundsson Pia; Skoog Ingmar; Waern Margda; Blennow Kaj; Pálsson Sigurdur; Rosengren Lars; Gustafson Deborah
The relationship between cerebrospinal fluid biomarkers and depression in elderly women.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2007;15(10):832-8.
2007: Nielsen H M; Minthon L; Londos E; Blennow K; Miranda E; Perez J; Crowther D C; Lomas D A; Janciauskiene S M
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.
Neurology 2007;69(16):1569-79.
2007: Anckarsäter Rolf; Zetterberg Henrik; Blennow Kaj; Anckarsäter Henrik
Association between thyroid hormone levels and monoaminergic neurotransmission during surgery.
Psychoneuroendocrinology 2007;32(8-10):1138-43.
2007: Zetterberg Henrik; Jonsson Michael; Rasulzada Abdullah; Popa Cornel; Styrud Ewa; Hietala Max Albert; Rosengren Lars; Wallin Anders; Blennow Kaj
No neurochemical evidence for brain injury caused by heading in soccer.
British journal of sports medicine 2007;41(9):574-7.
2007: Andersson Malin E; Sjölander Annica; Andreasen Niels; Minthon Lennart; Hansson Oskar; Bogdanovic Nenad; Jern Christina; Jood Katarina; Wallin Anders; Blennow Kaj; Zetterberg Henrik
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
International journal of molecular medicine 2007;20(2):233-9.
2007: Hansson Sara F; Simonsen Anja Hviid; Zetterberg Henrik; Andersen Oluf; Haghighi Sara; Fagerberg Inger; Andréasson Ulf; Westman-Brinkmalm Ann; Wallin Anders; Rüetschi Ulla; Blennow Kaj
Cystatin C in cerebrospinal fluid and multiple sclerosis.
Annals of neurology 2007;62(2):193-6; discussion 205.
2007: Paulson L; Martin P; Ljung E; Blennow K; Davidsson P
Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(7):885-91.
2007: Zetterberg Madeleine; Tasa Gunnar; Palmér Mona Seibt; Juronen Erkki; Toover Egle; Blennow Kaj; Zetterberg Henrik
Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma.
Ophthalmic genetics 2007;28(2):47-50.
2007: Zhong Zhenyu; Ewers Michael; Teipel Stefan; Bürger Katharina; Wallin Anders; Blennow Kaj; He Ping; McAllister Carrie; Hampel Harald; Shen Yong
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
Archives of general psychiatry 2007;64(6):718-26.
2007: Zetterberg Madeleine; Tasa Gunnar; Palmér Mona Seibt; Juronen Erkki; Teesalu Pait; Blennow Kaj; Zetterberg Henrik
Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.
American journal of ophthalmology 2007;143(6):1059-60.
2007: García-Ayllón María-Salud; Silveyra María-Ximena; Andreasen Niels; Brimijoin Stephen; Blennow Kaj; Sáez-Valero Javier
Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.
Journal of neurochemistry 2007;101(6):1701-11.
2007: Zetterberg Henrik; Hietala Max Albert; Wallin Anders; Blennow Kaj
[Guidelines for brain concussion in sports--how are they to be applied in boxing?]
Läkartidningen 2007;104(22):1715; author reply 1715-6.
2007: Berggren Ulf; Eriksson Matts; Fahlke Claudia; Blennow Kaj; Balldin Jan
Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects.
Alcohol and alcoholism (Oxford, Oxfordshire) 2007;42(3):267-71.
2007: Blennow Kaj; Zetterberg Henrik; Minthon Lennart; Lannfelt Lars; Strid Stig; Annas Peter; Basun Hans; Andreasen Niels
Longitudinal stability of CSF biomarkers in Alzheimer's disease.
Neuroscience letters 2007;419(1):18-22.
2007: Yamamori Hidenaga; Khatoon Sabiha; Grundke-Iqbal Inge; Blennow Kaj; Ewers Michael; Hampel Harald; Iqbal Khalid
Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.
Neuroscience letters 2007;418(2):186-9.
2007: Nylén Karin; Csajbok Ludwig Z; Ost Martin; Rashid Anas; Blennow Kaj; Nellgård Bengt; Rosengren Lars
Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage.
Stroke; a journal of cerebral circulation 2007;38(5):1489-94.
2007: Gustafson Deborah R; Skoog Ingmar; Rosengren Lars; Zetterberg Henrik; Blennow Kaj
Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women.
Journal of neurology, neurosurgery, and psychiatry 2007;78(5):461-4.
2007: Anckarsäter R; Vasic N; Jidéus L; Kristiansson M; Zetterberg H; Blennow K; Anckarsäter H
Cerebrospinal fluid protein reactions during non-neurological surgery.
Acta neurologica Scandinavica 2007;115(4):254-9.
2007: Tullberg M; Blennow K; Månsson J-E; Fredman P; Tisell M; Wikkelsö C
Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(3):248-54.
2007: Simonsen Anja H; McGuire James; Hansson Oskar; Zetterberg Henrik; Podust Vladimir N; Davies Huw A; Waldemar Gunhild; Minthon Lennart; Blennow Kaj
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.
Archives of neurology 2007;64(3):366-70.
2007: Mattsson Niklas; Haghighi Sara; Andersen Oluf; Yao Yuemang; Rosengren Lars; Blennow Kaj; Praticò Domenico; Zetterberg Henrik
Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients.
Neuroscience letters 2007;414(3):233-6.
2007: de Leon M J; Mosconi L; Blennow K; DeSanti S; Zinkowski R; Mehta P D; Pratico D; Tsui W; Saint Louis L A; Sobanska L; Brys M; Li Y; Rich K; Rinne J; Rusinek H
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.
Annals of the New York Academy of Sciences 2007;1097():114-45.
2007: Englund Hillevi; Annerén Göran; Gustafsson Jan; Wester Ulrika; Wiltfang Jens; Lannfelt Lars; Blennow Kaj; Höglund Kina
Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome.
Dementia and geriatric cognitive disorders 2007;24(5):369-74.
2007: Andersson Malin E; Zetterberg Madeleine; Tasa Gunnar; Seibt-Palmér Mona; Juronen Erkki; Teesalu Pait; Blennow Kaj; Zetterberg Henrik
Variability in the kinesin light chain 1 gene may influence risk of age-related cataract.
Molecular vision 2007;13():993-6.
2007: Stomrud Erik; Hansson Oskar; Blennow Kaj; Minthon Lennart; Londos Elisabet
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.
Dementia and geriatric cognitive disorders 2007;24(2):118-24.
2007: Höglund Kina; Blennow Kaj
Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
CNS drugs 2007;21(6):449-62.
2007: Hansson Oskar; Zetterberg Henrik; Buchhave Peder; Andreasson Ulf; Londos Elisabet; Minthon Lennart; Blennow Kaj
Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Dementia and geriatric cognitive disorders 2007;23(5):316-20.
2007: Simonsen A H; Hansson S F; Ruetschi U; McGuire J; Podust V N; Davies H A; Mehta P; Waldemar G; Zetterberg H; Andreasen N; Wallin A; Blennow K
Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.
Dementia and geriatric cognitive disorders 2007;23(4):246-50.
2007: Thorsell Annika; Portelius Erik; Blennow Kaj; Westman-Brinkmalm Ann
Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment.
Rapid communications in mass spectrometry : RCM 2007;21(5):771-8.
2007: Andersson Christin; Blennow Kaj; Johansson Sven-Erik; Almkvist Ove; Engfeldt Peter; Lindau Maria; Eriksdotter-Jönhagen Maria
Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.
Dementia and geriatric cognitive disorders 2007;23(2):87-95.
2006: Portelius Erik; Zetterberg Henrik; Andreasson Ulf; Brinkmalm Gunnar; Andreasen Niels; Wallin Anders; Westman-Brinkmalm Ann; Blennow Kaj
An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.
Neuroscience letters 2006;409(3):215-9.
2006: Ost M; Nylén K; Csajbok L; Ohrfelt A Olsson; Tullberg M; Wikkelsö C; Nellgård P; Rosengren L; Blennow K; Nellgård B
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.
Neurology 2006;67(9):1600-4.
2006: Zetterberg Henrik; Hietala M Albert; Jonsson Michael; Andreasen Niels; Styrud Ewa; Karlsson Ingvar; Edman Ake; Popa Cornel; Rasulzada Abdullah; Wahlund Lars-Olof; Mehta Pankaj D; Rosengren Lars; Blennow Kaj; Wallin Anders
Neurochemical aftermath of amateur boxing.
Archives of neurology 2006;63(9):1277-80.
2006: Berggren Ulf; Fahlke Claudia; Aronsson Erik; Karanti Aikaterini; Eriksson Matts; Blennow Kaj; Thelle Dag; Zetterberg Henrik; Balldin Jan
The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small.
Alcohol and alcoholism (Oxford, Oxfordshire) 2006;41(5):479-85.
2006: Merrill Charley A; Jonsson Michael A G; Minthon Lennart; Ejnell Hasse; C-son Silander Hans; Blennow Kaj; Karlsson Mats; Nordlund Arto; Rolstad Sindre; Warkentin Siegbert; Ben-Menachem Elinor; Sjögren Magnus J C
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
The Journal of clinical psychiatry 2006;67(8):1171-8.
2006: Zetterberg Henrik; Blennow Kaj
Plasma Abeta in Alzheimer's disease--up or down?
Lancet neurology 2006;5(8):638-9.
2006: Nylén K; Csajbok L Z; Ost M; Rashid A; Karlsson J-E; Blennow K; Nellgård B; Rosengren L
CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage.
Neuroscience letters 2006;404(1-2):132-6.
2006: Blennow Kaj; de Leon Mony J; Zetterberg Henrik
Alzheimer's disease.
Lancet 2006;368(9533):387-403.
2006: Blennow Kaj; Zetterberg Henrik
Pinpointing plaques with PIB.
Nature medicine 2006;12(7):753-4; discussion 754.
2006: Riemenschneider Matthias; Blennow Kaj; Wagenpfeil Stefan; Andreasen Niels; Prince Jonathan A; Laws Simon M; Förstl Hans; Kurz Alexander
The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.
Human mutation 2006;27(6):532-7.
2006: Nilselid A-M; Davidsson Pia; Nägga Katarina; Andreasen Niels; Fredman Pam; Blennow Kaj
Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.
Neurochemistry international 2006;48(8):718-28.
2006: Portelius Erik; Westman-Brinkmalm Ann; Zetterberg Henrik; Blennow Kaj
Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.
Journal of proteome research 2006;5(4):1010-6.
2006: Hansson Oskar; Zetterberg Henrik; Buchhave Peder; Londos Elisabet; Blennow Kaj; Minthon Lennart
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
Lancet neurology 2006;5(3):228-34.
2006: Blomqvist Mia E-L; Reynolds Chandra; Katzov Hagit; Feuk Lars; Andreasen Niels; Bogdanovic Nenad; Blennow Kaj; Brookes Anthony J; Prince Jonathan A
Towards compendia of negative genetic association studies: an example for Alzheimer disease.
Human genetics 2006;119(1-2):29-37.
2006: Mielke Michelle M; Zandi Peter P; Blennow Kaj; Gustafson Deborah; Sjögren Magnus; Rosengren Lars; Skoog Ingmar
Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.
Alzheimer disease and associated disorders 2006;20(1):30-6.
2006: Buerger Katharina; Otto Markus; Teipel Stefan J; Zinkowski Raymond; Blennow Kaj; DeBernardis John; Kerkman Daniel; Schröder Johannes; Schönknecht Peter; Cepek Lukas; McCulloch Cheryl; Möller Hans-Jürgen; Wiltfang Jens; Kretzschmar Hans; Hampel Harald
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Neurobiology of aging 2006;27(1):10-5.
2006: Nylén K; Ost M; Csajbok L Z; Nilsson I; Blennow K; Nellgård B; Rosengren L
Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.
Journal of the neurological sciences 2006;240(1-2):85-91.
2006: Vanderstichele Hugo; De Vreese Karen; Blennow Kaj; Andreasen Niels; Sindic Christian; Ivanoiu Adrian; Hampel Harald; Bürger Katharina; Parnetti Lucilla; Lanari Alessia; Padovani Allesandro; DiLuca Monica; Bläser Miriam; Olsson Annika Ohrfelt; Pottel Hans; Hulstaert Frank; Vanmechelen Eugeen
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(12):1472-80.
2006: Andersson Lars-Magnus; Hagberg Lars; Rosengren Lars; Fuchs Dietmar; Blennow Kaj; Gisslén Magnus
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report.
BMC infectious diseases 2006;6():141.
2006: Höglund K; Wallin A; Blennow K
Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
Acta neurologica Scandinavica. Supplementum 2006;185():87-92.
2006: Kivipelto M; Solomon A; Blennow K; Olsson A G; Winblad B
The new cholesterol controversy - a little bit of history repeating?
Acta neurologica Scandinavica. Supplementum 2006;185():1-2.
2006: Wallin A K; Blennow K; Andreasen N; Minthon L
CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.
Dementia and geriatric cognitive disorders 2006;21(3):131-8.
2006: Katzov Hagit; Bennet Anna M; Höglund Kina; Wiman Björn; Lütjohann Dieter; Brookes Anthony J; Andreasen Niels; Blennow Kaj; De Faire Ulf; Prince Jonathan A
Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels.
Journal of human genetics 2006;51(3):171-9.
2005: Wahlund Lars-Olof; Almkvist Ove; Blennow Kaj; Engedahl Knut; Johansson Aki; Waldemar Gunhild; Wolf Henrike
Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup.
Topics in magnetic resonance imaging : TMRI 2005;16(6):427-37.
2005: Blennow Kaj; Johansson Annica; Zetterberg Henrik
Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
International journal of molecular medicine 2005;16(6):1147-9.
2005: Buerger Katharina; Teipel Stefan J; Zinkowski Raymond; Sunderland Trey; Andreasen Niels; Blennow Kaj; Ewers Michael; DeBernardis John; Shen Yong; Kerkman Daniel; Du Yansheng; Hampel Harald
Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment.
Neuroscience letters 2005;391(1-2):48-50.
2005: Rüetschi Ulla; Zetterberg Henrik; Podust Vladimir N; Gottfries Johan; Li Susann; Hviid Simonsen Anja; McGuire James; Karlsson Mats; Rymo Lars; Davies Huw; Minthon Lennart; Blennow Kaj
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.
Experimental neurology 2005;196(2):273-81.
2005: Nilsson L K; Linderholm K R; Engberg G; Paulson L; Blennow K; Lindström L H; Nordin C; Karanti A; Persson P; Erhardt S
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.
Schizophrenia research 2005;80(2-3):315-22.
2005: Zetterberg Madeleine; Tasa Gunnar; Prince Jonathan A; Palmér Mona; Juronen Erkki; Veromann Siiri; Teesalu Pait; Karlsson Jan-Olof; Blennow Kaj; Zetterberg Henrik
Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract.
American journal of ophthalmology 2005;140(5):932-4.
2005: Buerger K; Ewers M; Andreasen N; Zinkowski R; Ishiguro K; Vanmechelen E; Teipel S J; Graz C; Blennow K; Hampel H
Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.
Neurology 2005;65(9):1502-3.
2005: Brew B J; Pemberton L; Blennow K; Wallin A; Hagberg L
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.
Neurology 2005;65(9):1490-2.
2005: Iqbal Khalid; Flory Michael; Khatoon Sabiha; Soininen Hilkka; Pirttila Tuula; Lehtovirta Maarit; Alafuzoff Irina; Blennow Kaj; Andreasen Niels; Vanmechelen Eugeen; Grundke-Iqbal Inge
Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.
Annals of neurology 2005;58(5):748-57.
2005: Blennow Kaj; Popa Cornel; Rasulzada Abdullah; Minthon Lennart; Wallin Anders; Zetterberg Henrik
[There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk]
Läkartidningen 2005;102(36):2468-70, 2472-5.
2005: Blennow Kaj
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.
Expert review of molecular diagnostics 2005;5(5):661-72.
2005: Vanderstichele Hugo; De Meyer Geert; Andreasen Niels; Kostanjevecki Vesna; Wallin Anders; Olsson Annika; Blennow Kaj; Vanmechelen Eugeen
Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.
Clinical chemistry 2005;51(9):1650-60.
2005: Höglund Kina; Syversen Steinar; Lewczuk Piotr; Wallin Anders; Wiltfang Jens; Blennow Kaj
Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 2005;164(2):205-14.
2005: Anckarsäter H; Forsman A; Blennow K
Increased CSF/serum albumin ratio: a recurrent finding in violent offenders.
Acta neurologica Scandinavica 2005;112(1):48-50.
2005: Blomqvist Mia E-L; Chalmers Katy; Andreasen Niels; Bogdanovic Nenad; Wilcock Gordon K; Cairns Nigel J; Feuk Lars; Brookes Anthony J; Love Seth; Blennow Kaj; Kehoe Patrick G; Prince Jonathan A
Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
Neurobiology of aging 2005;26(6):795-802.
2005: Andreasen Niels; Blennow Kaj
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
Clinical neurology and neurosurgery 2005;107(3):165-73.
2005: Zetterberg Henrik; Hammarin Anna-Lena; Nilsson Petra; Andersson Elsa; Lind Börje; Blennow Kaj
[New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis]
Läkartidningen 2005;102(12-13):956-8, 960-1.
2005: Olsson Annika; Vanderstichele Hugo; Andreasen Niels; De Meyer Geert; Wallin Anders; Holmberg Björn; Rosengren Lars; Vanmechelen Eugeen; Blennow Kaj
Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.
Clinical chemistry 2005;51(2):336-45.
2005: Molander-Melin Marie; Blennow Kaj; Bogdanovic Nenad; Dellheden Birgitta; Månsson Jan-Eric; Fredman Pam
Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains.
Journal of neurochemistry 2005;92(1):171-82.
2005: Johansson Annica; Zetterberg Henrik; Håkansson Anna; Nissbrandt Hans; Blennow Kaj
TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Neuro-degenerative diseases 2005;2(1):28-35.
2005: Westman-Brinkmalm Ann; Karlsson Gösta; Brive Lena M; Hedberg-Fogel Kristina; Persson Rita; Karlsson Hasse; Ekman Rolf; Blennow Kaj
Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 2005;19(24):3651-8.
2005: Johansson Annica; Zetterberg Henrik; Hampel Harald; Buerger Katharina; Prince Jonathan A; Minthon Lennart; Wahlund Lars-Olof; Blennow Kaj
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2005;20(6):367-74.
2005: Sjögren Magnus; Blennow Kaj
The link between cholesterol and Alzheimer's disease.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(2):85-97.
2005: Wiltfang J; Lewczuk P; Riederer P; Grünblatt E; Hock C; Scheltens P; Hampel H; Vanderstichele H; Iqbal K; Galasko D; Lannfelt L; Otto M; Esselmann H; Henkel A W; Kornhuber J; Blennow K
Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(2):69-84.
2005: Hoglund K; Thelen K M; Syversen S; Sjogren M; von Bergmann K; Wallin A; Vanmechelen E; Vanderstichele H; Lutjohann D; Blennow K
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2005;19(5-6):256-65.
2005: Nagga Katarina; Garcia Jorge; Zetterberg Henrik; Blennow Kaj; Gottfries Johan; Marcusson Jan
Evaluation of factors of importance for clinical dementia diagnosis.
Dementia and geriatric cognitive disorders 2005;19(5-6):289-98.
2004: Zetterberg H; Blennow K
Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2004;25(5):301-2.
2004: Soderstrom H; Blennow K; Forsman A; Liesivuori J; Pennanen S; Tiihonen J
A controlled study of tryptophan and cortisol in violent offenders.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(12):1605-10.
2004: Strandhagen Elisabeth; Zetterberg Henrik; Aires Nibia; Palmér Mona; Rymo Lars; Blennow Kaj; Thelle Dag S
The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee.
Lipids in health and disease 2004;3():26.
2004: Paulson Linda; Martin Peter; Ljung Elisabeth; Blennow Kaj; Davidsson Pia
Effects on rat thalamic proteome by acute and subchronic MK-801-treatment.
European journal of pharmacology 2004;505(1-3):103-9.
2004: Katzov Hagit; Bennet Anna M; Kehoe Patrick; Wiman Björn; Gatz Margaret; Blennow Kaj; Lenhard Boris; Pedersen Nancy L; de Faire Ulf; Prince Jonathan A
A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity.
Human molecular genetics 2004;13(21):2647-57.
2004: Zetterberg Henrik; Andreasen Niels; Blennow Kaj
Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.
Neuroscience letters 2004;367(2):194-6.
2004: Winblad B; Palmer K; Kivipelto M; Jelic V; Fratiglioni L; Wahlund L-O; Nordberg A; Bäckman L; Albert M; Almkvist O; Arai H; Basun H; Blennow K; de Leon M; DeCarli C; Erkinjuntti T; Giacobini E; Graff C; Hardy J; Jack C; Jorm A; Ritchie K; van Duijn C; Visser P; Petersen R C
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
Journal of internal medicine 2004;256(3):240-6.
2004: Blennow K
CSF biomarkers for mild cognitive impairment.
Journal of internal medicine 2004;256(3):224-34.
2004: Sjögren M; Folkesson S; Blennow K; Tarkowski E
Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications.
Journal of neurology, neurosurgery, and psychiatry 2004;75(8):1107-11.
2004: Olsson Annika; Csajbok Ludvig; Ost Martin; Höglund Kina; Nylén Karin; Rosengren Lars; Nellgård Bengt; Blennow Kaj
Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
Journal of neurology 2004;251(7):870-6.
2004: Schmitt Andrea; Wilczek Katrin; Blennow Kaj; Maras Athanasios; Jatzko Alexander; Petroianu Georg; Braus Dieter F; Gattaz Wagner F
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
Biological psychiatry 2004;56(1):41-5.
2004: Ryberg Henrik; Söderling Ann-Sofi; Davidsson Pia; Blennow Kaj; Caidahl Kenneth; Persson Lennart I
Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
Neurochemistry international 2004;45(1):57-62.
2004: Hampel H; Teipel S J; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller H-J; Blennow K; Buerger K
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Molecular psychiatry 2004;9(7):705-10.
2004: Prince J A; Zetterberg H; Andreasen N; Marcusson J; Blennow K
APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.
Neurology 2004;62(11):2116-8.
2004: Strandhagen Elisabeth; Zetterberg Henrik; Aires Nibia; Palmér Mona; Rymo Lars; Blennow Kaj; Landaas Sverre; Thelle Dag S
The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study.
International journal of molecular medicine 2004;13(6):811-5.
2004: Blomqvist Mia E-L; Silburn Peter A; Buchanan Daniel D; Andreasen Niels; Blennow Kaj; Pedersen Nancy L; Brookes Anthony J; Mellick George D; Prince Jonathan A
Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.
Neurogenetics 2004;5(2):115-9.
2004: Regland B; Abrahamsson L; Blennow K; Grenfeldt B; Gottfries C-G
CSF-methionine is elevated in psychotic patients.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(5):631-40.
2004: Johansson Annica; Katzov Hagit; Zetterberg Henrik; Feuk Lars; Johansson Boo; Bogdanovic Nenad; Andreasen Niels; Lenhard Boris; Brookes Anthony J; Pedersen Nancy L; Blennow Kaj; Prince Jonathan A
Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.
Human genetics 2004;114(6):581-7.
2004: Blennow Kaj
Cerebrospinal fluid protein biomarkers for Alzheimer's disease.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(2):213-25.
2004: Blomqvist Mia E-L; Andreasen Niels; Bogdanovic Nenad; Blennow Kaj; Brookes Anthony J; Prince Jonathan A
Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.
Neuroscience letters 2004;358(3):220-2.
2004: Katzov Hagit; Chalmers Katy; Palmgren Juni; Andreasen Niels; Johansson Boo; Cairns Nigel J; Gatz Margaret; Wilcock Gordon K; Love Seth; Pedersen Nancy L; Brookes Anthony J; Blennow Kaj; Kehoe Patrick G; Prince Jonathan A
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
Human mutation 2004;23(4):358-67.
2004: Kehoe Patrick G; Katzov Hagit; Andreasen Niels; Gatz Maragaret; Wilcock Gordon K; Cairns Nigel J; Palmgren Juni; de Faire Ulf; Brookes Anthony J; Pedersen Nancy L; Blennow Kaj; Prince Jonathan A
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
Human genetics 2004;114(5):478-83.
2004: Höglund Kina; Wiklund Olov; Vanderstichele Hugo; Eikenberg Oliver; Vanmechelen Eugeen; Blennow Kaj
Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.
Archives of neurology 2004;61(3):333-7.
2004: Paulson Linda; Martin Peter; Nilsson Carol L; Ljung Elisabeth; Westman-Brinkmalm Ann; Blennow Kaj; Davidsson Pia
Comparative proteome analysis of thalamus in MK-801-treated rats.
Proteomics 2004;4(3):819-25.
2004: Hampel H; Mitchell A; Blennow K; Frank R A; Brettschneider S; Weller L; Möller H-J
Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(3):247-72.
2004: Diamandis Eleftherios P; Scorilas Andreas; Kishi Tadaaki; Blennow Kaj; Luo Liu-Ying; Soosaipillai Antoninus; Rademaker Alfred W; Sjogren Magnus
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Clinical biochemistry 2004;37(3):230-7.
2004: Blennow Kaj; Nellgård Bengt
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.
Neurology 2004;62(1):159; author reply 159-60.
2004: Hampel Harald; Buerger Katharina; Zinkowski Raymond; Teipel Stefan J; Goernitz Alexander; Andreasen Niels; Sjoegren Magnus; DeBernardis John; Kerkman Daniel; Ishiguro Koichi; Ohno Hideto; Vanmechelen Eugeen; Vanderstichele Hugo; McCulloch Cheryl; Moller Hans-Jurgen; Davies Peter; Blennow Kaj
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Archives of general psychiatry 2004;61(1):95-102.
2004: Tisell M; Tullberg M; Månsson J-E; Fredman P; Blennow K; Wikkelsø C
Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2004;11(1):17-23.
2004: Trysberg Estelle; Blennow Kaj; Zachrisson Olof; Tarkowski Andrej
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Arthritis research & therapy 2004;6(6):R551-6.
2004: Trysberg Estelle; Höglund Kina; Svenungsson Elisabet; Blennow Kaj; Tarkowski Andrej
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus.
Arthritis research & therapy 2004;6(2):R129-36.
2004: McCaddon Andrew; Blennow Kaj; Hudson Peter; Hughes Alan; Barber Joan; Gray Rob; Davies Gareth; Williams John H H; Duguid Jennifer; Lloyd Alwyn; Tandy Steve; Everall Marge; Cattell Howard; McCaddon Anne; Ellis Dick; Palmer Mona; Bogdanovic Nenad; Gottfries Carl-Gerhard; Zetterberg Henrik; Rymo Lars; Regland Björn
Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease.
Dementia and geriatric cognitive disorders 2004;17(3):215-21.
2003: Yhede R; Blennow K; Forsman A; Soderstrom H
The activity in the CNS catecholaminergic systems covaries with thyroid hormone metabolism in humans.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(12):1369-73.
2003: Zetterberg Henrik; Wahlund Lars-Olof; Blennow Kaj
Cerebrospinal fluid markers for prediction of Alzheimer's disease.
Neuroscience letters 2003;352(1):67-9.
2003: Prince Jonathan A; Feuk Lars; Gu Harvest F; Johansson Boo; Gatz Margaret; Blennow Kaj; Brookes Anthony J
Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.
Human mutation 2003;22(5):363-71.
2003: Andreasen Niels; Sjögren Magnus; Blennow Kaj
CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(4):147-55.
2003: Puchades Maja; Hansson Sara Folkesson; Nilsson Carol L; Andreasen Niels; Blennow Kaj; Davidsson Pia
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.
Brain research. Molecular brain research 2003;118(1-2):140-6.
2003: Johansson Anders; Larsson Anders; Nygren Ingela; Blennow Kaj; Askmark Håkan
Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis.
Neuroreport 2003;14(14):1867-9.
2003: Blennow Kaj; Hampel Harald
CSF markers for incipient Alzheimer's disease.
Lancet neurology 2003;2(10):605-13.
2003: Olsson Annika; Höglund Kina; Sjögren Magnus; Andreasen Niels; Minthon Lennart; Lannfelt Lars; Buerger Katharina; Möller Hans Jürgen; Hampel Harald; Davidsson Pia; Blennow Kaj
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
Experimental neurology 2003;183(1):74-80.
2003: Tarkowski E; Andreasen N; Tarkowski A; Blennow K
Intrathecal inflammation precedes development of Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2003;74(9):1200-5.
2003: Zetterberg Henrik; Zafiropoulos Alexis; Spandidos Demetrios A; Rymo Lars; Blennow Kaj
Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion.
Human reproduction (Oxford, England) 2003;18(9):1948-50.
2003: Tarkowski Elisabeth; Liljeroth Ann Marie; Minthon Lennart; Tarkowski Andrzej; Wallin Anders; Blennow Kaj
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias.
Brain research bulletin 2003;61(3):255-60.
2003: Blennow Kaj; Vanmechelen Eugeen
CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry.
Brain research bulletin 2003;61(3):235-42.
2003: Davidsson P; Brinkmalm A; Karlsson G; Persson R; Lindbjer M; Puchades M; Folkesson S; Paulson L; Dahl A; Rymo L; Silberring J; Ekman R; Blennow K
Clinical mass spectrometry in neuroscience. Proteomics and peptidomics.
Cellular and molecular biology (Noisy-le-Grand, France) 2003;49(5):681-8.
2003: Gustafson Deborah; Rothenberg Elisabet; Blennow Kaj; Steen Bertil; Skoog Ingmar
An 18-year follow-up of overweight and risk of Alzheimer disease.
Archives of internal medicine 2003;163(13):1524-8.
2003: Zetterberg Henrik; Nexö Ebba; Regland Björn; Minthon Lennart; Boson Roberta; Palmér Mona; Rymo Lars; Blennow Kaj
The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease.
Clinical chemistry 2003;49(7):1195-8.
2003: Soderstrom H; Blennow K; Sjodin A-K; Forsman A
New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits.
Journal of neurology, neurosurgery, and psychiatry 2003;74(7):918-21.
2003: Sjögren Magnus; Andreasen Niels; Blennow Kaj
Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.
Clinica chimica acta; international journal of clinical chemistry 2003;332(1-2):1-10.
2003: Zetterberg Henrik; Palmér Mona; Boreström Cecilia; Rymo Lars; Blennow Kaj
The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C.
Blood 2003;101(9):3749-50; author reply 3750-1.
2003: Sáez-Valero J; Fodero L R; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small D H
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
Journal of neuroscience research 2003;72(4):520-6.
2003: Kehoe Patrick G; Katzov Hagit; Feuk Lars; Bennet Anna M; Johansson Boo; Wiman Björn; de Faire Ulf; Cairns Nigel J; Wilcock Gordon K; Brookes Anthony J; Blennow Kaj; Prince Jonathan A
Haplotypes extending across ACE are associated with Alzheimer's disease.
Human molecular genetics 2003;12(8):859-67.
2003: Johansson A; Hampel H; Faltraco F; Buerger K; Minthon L; Bogdanovic N; Sjögren M; Zetterberg H; Forsell L; Lilius L; Wahlund L O; Rymo L; Prince J A; Blennow K
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia.
Neuroscience letters 2003;340(1):69-73.
2003: Sáez-Valero Javier; Costell Mercedes; Sjögren Magnus; Andreasen Niels; Blennow Kaj; Luque Juan M
Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.
Journal of neuroscience research 2003;72(1):132-6.
2003: Wahlund Lars-Olov; Blennow Kaj
Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients.
Neuroscience letters 2003;339(2):99-102.
2003: Hamberger Anders; Huang Ying-Lai; Zhu Hong; Bao Feng; Ding Mei; Blennow Kaj; Olsson Annika; Hansson Hans-Arne; Viano David; Haglid Kenneth G
Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head.
Journal of neurotrauma 2003;20(2):169-78.
2003: Strozyk D; Blennow K; White L R; Launer L J
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.
Neurology 2003;60(4):652-6.
2003: Stefanova E; Blennow K; Almkvist O; Hellström-Lindahl E; Nordberg A
Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients.
Neuroscience letters 2003;338(2):159-63.
2003: Paulson Linda; Martin Peter; Persson Anders; Nilsson Carol L; Ljung Elisabeth; Westman-Brinkmalm Ann; Eriksson Peter S; Blennow Kaj; Davidsson Pia
Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats.
Journal of neuroscience research 2003;71(4):526-33.
2003: Holmberg Björn; Johnels Bo; Blennow Kaj; Rosengren Lars
Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2003;18(2):186-90.
2003: Feuk Lars; Prince Jonathan A; Blennow Kaj; Brookes Anthony J
Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.
Human mutation 2003;21(1):53-60.
2003: Wallin Anders; Sjögren Magnus; Blennow Kaj; Davidsson Pia
Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia.
Dementia and geriatric cognitive disorders 2003;16(4):200-7.
2003: Lehmann Martin; Regland Björn; Blennow Kaj; Gottfries C G
Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment.
Dementia and geriatric cognitive disorders 2003;16(3):145-50.
2003: Sun Yong-Xin; Minthon L; Wallmark A; Warkentin S; Blennow K; Janciauskiene S
Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2003;16(3):136-44.
2003: Olsson Annika; Vanmechelen Eugeen; Vanderstichele Hugo; Davidsson Pia; Blennow Kaj
Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets.
Dementia and geriatric cognitive disorders 2003;16(2):93-7.
2003: Sjögren Magnus; Gustafsson Kina; Syversen Steinar; Olsson Annika; Edman Ake; Davidsson Pia; Wallin Anders; Blennow Kaj
Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein.
Dementia and geriatric cognitive disorders 2003;16(1):25-30.
2003: Andreasen Niels; Vanmechelen Eugeen; Vanderstichele Hugo; Davidsson Pia; Blennow Kaj
Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment.
Acta neurologica Scandinavica. Supplementum 2003;179():47-51.
2003: Skoog I; Davidsson P; Aevarsson O; Vanderstichele H; Vanmechelen E; Blennow K
Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.
Dementia and geriatric cognitive disorders 2003;15(3):169-76.
2002: Davidsson Pia; Sjögren Magnus; Andreasen Niels; Lindbjer Maria; Nilsson Carol L; Westman-Brinkmalm Ann; Blennow Kaj
Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins.
Brain research. Molecular brain research 2002;109(1-2):128-33.
2002: Zetterberg H; Regland B; Palmér M; Rymo L; Zafiropoulos A; Arvanitis D A; Spandidos D A; Blennow K
The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion.
Human reproduction (Oxford, England) 2002;17(12):3033-6.
2002: Zetterberg Henrik; Coppola Antonio; D'Angelo Armando; Palmér Mona; Rymo Lars; Blennow Kaj
No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease.
Thrombosis research 2002;108(2-3):127-31.
2002: Berggren Ulf; Eriksson Matts; Fahlke Claudia; Blennow Kaj; Balldin Jan
Platelet monoamine oxidase B in family history positive and family history negative type 1 alcohol-dependent subjects.
Alcohol and alcoholism (Oxford, Oxfordshire) 2002;37(6):577-80.
2002: Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S95-6.
2002: Buerger K; Teipel S J; Zinkowski R; Blennow K; Arai H; Engel R; Hofmann-Kiefer K; McCulloch C; Ptok U; Heun R; Andreasen N; DeBernardis J; Kerkman D; Moeller H- J; Davies P; Hampel H
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.
Neurology 2002;59(4):627-9.
2002: Buerger Katharina; Zinkowski Raymond; Teipel Stefan J; Tapiola Tero; Arai Hiroyuki; Blennow Kaj; Andreasen Niels; Hofmann-Kiefer Klaus; DeBernardis John; Kerkman Daniel; McCulloch Cheryl; Kohnken Russell; Padberg Frank; Pirttilä Tuula; Schapiro Marc B; Rapoport Stanley I; Möller Hans-Jürgen; Davies Peter; Hampel Harald
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Archives of neurology 2002;59(8):1267-72.
2002: Andreasen Niels; Blennow Kaj
Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease.
Peptides 2002;23(7):1205-14.
2002: Berggren Ulf; Eriksson Matts; Fahlke Claudia; Blennow Kaj; Sundkler Anders; Balldin Jan
Platelet monoamine oxidase-B activity in type 1 alcohol-dependent subjects in sustained full remission.
Alcohol and alcoholism (Oxford, Oxfordshire) 2002;37(4):340-3.
2002: Sjögren Magnus; Blennow Kaj
[A new putative principle for diagnosis of Creutzfeldt-Jakob disease]
Läkartidningen 2002;99(21):2382-4.
2002: Zetterberg Henrik; Palmér Mona; Ricksten Anne; Poirier Judes; Palmqvist Lars; Rymo Lars; Zafiropoulos Alexander; Arvanitis Demetrios A; Spandidos Demetrios A; Blennow Kaj
Influence of the apolipoprotein E epsilon4 allele on human embryonic development.
Neuroscience letters 2002;324(3):189-92.
2002: Landén Mikael; Davidsson Pia; Gottfries Carl-Gerhard; Månsson Jan-Eric; Blennow Kaj
Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia.
Schizophrenia research 2002;55(1-2):83-8.
2002: Davidsson Pia; Westman-Brinkmalm Ann; Nilsson Carol L; Lindbjer Maria; Paulson Linda; Andreasen Niels; Sjögren Magnus; Blennow Kaj
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients.
Neuroreport 2002;13(5):611-5.
2002: Tarkowski Elisabeth; Issa Razao; Sjögren Magnus; Wallin Anders; Blennow Kaj; Tarkowski Andrej; Kumar Pat
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.
Neurobiology of aging 2002;23(2):237-43.
2002: Zetterberg Henrik; Regland Björn; Palmér Mona; Ricksten Anne; Palmqvist Lars; Rymo Lars; Arvanitis Demetrios A; Spandidos Demetrios A; Blennow Kaj
Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos.
European journal of human genetics : EJHG 2002;10(2):113-8.
2002: Mathé Aleksander A; Agren Hans; Wallin Anders; Blennow Kaj
Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: possible disease markers.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):41-8.
2002: Davidsson P; Folkesson S; Christiansson M; Lindbjer M; Dellheden B; Blennow K; Westman-Brinkmalm A
Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry.
Rapid communications in mass spectrometry : RCM 2002;16(22):2083-8.
2002: Sjögren Magnus; Wikkelsö Carsten; Ostling Svante; Wallin Anders; Blennow Kaj
Biological correlates of clinical subgroups of Alzheimer's disease.
Dementia and geriatric cognitive disorders 2002;14(4):191-7.
2002: Nägga Katarina; Gottfries Johan; Blennow Kaj; Marcusson Jan
Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia.
Dementia and geriatric cognitive disorders 2002;14(4):183-90.
2002: Sjögren Magnus; Davidsson Pia; Wallin Anders; Granérus Ann-Kathrine; Grundström Eva; Askmark Håkan; Vanmechelen Eugeen; Blennow Kaj
Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
Dementia and geriatric cognitive disorders 2002;13(2):112-8.
2002: Sundman-Eriksson Ingrid; Blennow Kaj; Davidsson Pia; Dandenell Anna-Karin; Marcusson Jan
Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia.
Neuropsychobiology 2002;45(1):7-11.
2001: Nilsson C L; Brinkmalm A; Minthon L; Blennow K; Ekman R
Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Peptides 2001;22(12):2105-12.
2001: McCaddon A; Blennow K; Hudson P; Regland B; Hill D
Transcobalamin polymorphism and homocysteine.
Blood 2001;98(12):3497-9.
2001: Sjögren M; Blomberg M; Jonsson M; Wahlund L O; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Journal of neuroscience research 2001;66(3):510-6.
2001: Sjögren M; Gisslén M; Vanmechelen E; Blennow K
Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment.
Neuroscience letters 2001;314(1-2):33-6.
2001: Erhardt S; Blennow K; Nordin C; Skogh E; Lindström L H; Engberg G
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.
Neuroscience letters 2001;313(1-2):96-8.
2001: Regland B; Lehmann W; Abedini I; Blennow K; Jonsson M; Karlsson I; Sjögren M; Wallin A; Xilinas M; Gottfries C G
Treatment of Alzheimer's disease with clioquinol.
Dementia and geriatric cognitive disorders 2001;12(6):408-14.
2001: Vanmechelen E; Vanderstichele H; Hulstaert F; Andreasen N; Minthon L; Winblad B; Davidsson P; Blennow K
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders.
Mechanisms of ageing and development 2001;122(16):2005-11.
2001: Sjögren M; Vanderstichele H; Agren H; Zachrisson O; Edsbagge M; Wikkelsø C; Skoog I; Wallin A; Wahlund L O; Marcusson J; Nägga K; Andreasen N; Davidsson P; Vanmechelen E; Blennow K
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.
Clinical chemistry 2001;47(10):1776-81.
2001: Andreasen N; Gottfries J; Vanmechelen E; Vanderstichele H; Davidson P; Blennow K; Rosengren L; Blennow K
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;71(4):557-8.
2001: Andreasen N; Gottfries J; Vanmechelen E; Vanderstichele H; Davidson P; Blennow K; Rosengren L; Blennow K
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;71(4):557-8.
2001: Tarkowski E; Liljeroth A M; Nilsson A; Minthon L; Blennow K
Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2001;12(5):314-7.
2001: Blennow K; Vanmechelen E; Hampel H
CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.
Molecular neurobiology 2001;24(1-3):87-97.
2001: Sjögren M; Davidsson P; Gottfries J; Vanderstichele H; Edman A; Vanmechelen E; Wallin A; Blennow K
The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process.
Dementia and geriatric cognitive disorders 2001;12(4):257-64.
2001: Davidsson P; Bogdanovic N; Lannfelt L; Blennow K
Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2001;12(4):243-50.
2001: Prince J A; Feuk L; Sawyer S L; Gottfries J; Ricksten A; Nägga K; Bogdanovic N; Blennow K; Brookes A J
Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease.
European journal of human genetics : EJHG 2001;9(6):437-44.
2001: Eriksson M; Berggren U; Blennow K; Fahlke C; Balldin J
Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype.
Alcohol (Fayetteville, N.Y.) 2001;24(1):15-23.
2001: Blennow K; Lind B; Andersson E; Andreasen N
[CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice]
Läkartidningen 2001;98(20):2446-51.
2001: Hesse C; Nilsson C L; Blennow K; Davidsson P
Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry.
Electrophoresis 2001;22(9):1834-7.
2001: Sjögren M; Davidsson P; Tullberg M; Minthon L; Wallin A; Wikkelso C; Granérus A K; Vanderstichele H; Vanmechelen E; Blennow K
Both total and phosphorylated tau are increased in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(5):624-30.
2001: Fabre S F; Forsell C; Viitanen M; Sjögren M; Wallin A; Blennow K; Blomberg M; Andersen C; Wahlund L O; Lannfelt L
Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations.
Experimental neurology 2001;168(2):413-8.
2001: Davidsson P; Paulson L; Hesse C; Blennow K; Nilsson C L
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry.
Proteomics 2001;1(3):444-52.
2001: Andreasen N; Minthon L; Davidsson P; Vanmechelen E; Vanderstichele H; Winblad B; Blennow K
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.
Archives of neurology 2001;58(3):373-9.
2001: Tarkowski E; Wallin A; Regland B; Blennow K; Tarkowski A
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia.
Acta neurologica Scandinavica 2001;103(3):166-74.
2001: Davidsson P; Blennow K; Andreasen N; Eriksson B; Minthon L; Hesse C
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.
Neuroscience letters 2001;300(3):157-60.
2001: Robertsson B; Blennow K; Bråne G; Edman A; Karlsson I; Wallin A; Gottfries C G
Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium.
International clinical psychopharmacology 2001;16(1):39-47.
2001: Prince J A; Feuk L; Howell W M; Jobs M; Emahazion T; Blennow K; Brookes A J
Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation.
Genome research 2001;11(1):152-62.
2001: Hesse C; Rosengren L; Andreasen N; Davidsson P; Vanderstichele H; Vanmechelen E; Blennow K
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.
Neuroscience letters 2001;297(3):187-90.
2001: Chamoun V; Zeman A; Blennow K; Fredman P; Wallin A; Keir G; Giovannoni G; Thompson E J
Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.
Journal of the neurological sciences 2001;182(2):117-21.
2001: Gottfries J; Blennow K; Lehmann M W; Regland B; Gottfries C G
One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis.
Journal of geriatric psychiatry and neurology 2001;14(3):109-14.
2001: Soderstrom H; Blennow K; Manhem A; Forsman A
CSF studies in violent offenders. II. Blood-brain barrier dysfunction without concurrent inflammation or structure degeneration.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(7):879-86.
2001: Soderstrom H; Blennow K; Manhem A; Forsman A
CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(7):869-78.
2001: Sjögren M; Hesse C; Basun H; Köl G; Thostrup H; Kilander L; Marcusson J; Edman A; Wallin A; Karlsson I; Troell M; Wachtmaister G; Ekdahl A; Olofsson H; Sandström A; Andreasen N; Minthon L; Blennow K
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(4):451-8.
2000: Vanderstichele H; Van Kerschaver E; Hesse C; Davidsson P; Buyse M A; Andreasen N; Minthon L; Wallin A; Blennow K; Vanmechelen E
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2000;7(4):245-58.
2000: Hesse C; Rosengren L; Vanmechelen E; Vanderstichele H; Jensen C; Davidsson P; Blennow K
Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.
Journal of Alzheimer's disease : JAD 2000;2(3-4):199-206.
2000: Tarkowski E; Ringqvist A; Blennow K; Wallin A; Wennmalm A
Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia.
Dementia and geriatric cognitive disorders 2000;11(6):322-6.
2000: Zachrisson O C; Balldin J; Ekman R; Naesh O; Rosengren L; Agren H; Blennow K
No evident neuronal damage after electroconvulsive therapy.
Psychiatry research 2000;96(2):157-65.
2000: Eriksson M; Berggren U; Blennow K; Fahlke C; Månsson J E; Balldin J
Alcoholics with the dopamine receptor DRD2 A1 allele have lower platelet monoamine oxidase-B activity than those with the A2 allele: a preliminary study.
Alcohol and alcoholism (Oxford, Oxfordshire) 2000;35(5):493-8.
2000: Tullberg M; Månsson J E; Fredman P; Lekman A; Blennow K; Ekman R; Rosengren L E; Tisell M; Wikkelsø C
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.
Journal of neurology, neurosurgery, and psychiatry 2000;69(1):74-81.
2000: Grundström E; Lindholm D; Johansson A; Blennow K; Askmark H
GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis.
Neuroreport 2000;11(8):1781-3.
2000: Tarkowski E; Liljeroth A M; Nilsson A; Ricksten A; Davidsson P; Minthon L; Blennow K
TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.
Neurology 2000;54(11):2077-81.
2000: Sjögren M; Rosengren L; Minthon L; Davidsson P; Blennow K; Wallin A
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.
Neurology 2000;54(10):1960-4.
2000: Vanmechelen E; Vanderstichele H; Davidsson P; Van Kerschaver E; Van Der Perre B; Sjögren M; Andreasen N; Blennow K
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.
Neuroscience letters 2000;285(1):49-52.
2000: Hesse C; Larsson H; Fredman P; Minthon L; Andreasen N; Davidsson P; Blennow K
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
Neurochemical research 2000;25(4):511-7.
2000: Prince J A; Harro J; Blennow K; Gottfries C G; Oreland L
Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(3):284-92.
2000: Blennow K; Minthon L; Wallin A
[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis]
Läkartidningen 2000;97(1-2):6-10.
2000: Bogdanovic N; Davidsson P; Volkmann I; Winblad B; Blennow K
Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(4):463-78.
2000: Wallin A; Sjögren M; Edman A; Blennow K; Regland B
Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia.
European neurology 2000;44(4):229-35.
2000: Sjögren M; Minthon L; Davidsson P; Granérus A-K; Clarberg A; Vanderstichele H; Vanmechelen E; Wallin A; Blennow K
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(5):563-79.
2000: Blennow K; Bogdanovic N; Heilig M; Grenfeldt B; Karlsson I; Davidsson P
Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(8-9):1085-97.
2000: Blennow K; Ricksten A; Prince J A; Brookes A J; Emahazion T; Wasslavik C; Bogdanovic N; Andreasen N; Båtsman S; Marcusson J; Nägga K; Wallin A; Regland B; Olofsson H; Hesse C; Davidsson P; Minthon L; Jansson A; Palmqvist L; Rymo L
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(8-9):1065-79.
1999: Landén M; Davidsson P; Gottfries C G; Grenfeldt B; Stridsberg M; Blennow K
Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia.
Biological psychiatry 1999;46(12):1698-702.
1999: Andersson L; Blennow K; Fuchs D; Svennerholm B; Gisslén M
Increased cerebrospinal fluid protein tau concentration in neuro-AIDS.
Journal of the neurological sciences 1999;171(2):92-6.
1999: Hesse C; Bogdanovic N; Davidsson P; Blennow K
A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease.
Dementia and geriatric cognitive disorders 1999;10(6):452-9.
1999: Davidsson P; Gottfries J; Bogdanovic N; Ekman R; Karlsson I; Gottfries C G; Blennow K
The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains.
Schizophrenia research 1999;40(1):23-9.
1999: Wallin A; Blennow K; Rosengren L
Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S102-5.
1999: Andreasen N; Minthon L; Clarberg A; Davidsson P; Gottfries J; Vanmechelen E; Vanderstichele H; Winblad B; Blennow K
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.
Neurology 1999;53(7):1488-94.
1999: Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L
Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9(5):399-405.
1999: Andreasen N; Minthon L; Vanmechelen E; Vanderstichele H; Davidsson P; Winblad B; Blennow K
Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment.
Neuroscience letters 1999;273(1):5-8.
1999: Prince J A; Blennow K; Gottfries C G; Karlsson I; Oreland L
Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(3):372-9.
1999: Blennow K; Bogdanovic N; Gottfries C G; Davidsson P
The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia.
Journal of molecular neuroscience : MN 1999;13(1-2):101-9.
1999: Tarkowski E; Blennow K; Wallin A; Tarkowski A
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.
Journal of clinical immunology 1999;19(4):223-30.
1999: Regland B; Blennow K; Germgård T; Koch-Schmidt A C; Gottfries C G
The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.
Dementia and geriatric cognitive disorders 1999;10(4):245-51.
1999: Guan Z Z; Zhang X; Blennow K; Nordberg A
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain.
Neuroreport 1999;10(8):1779-82.
1999: Landén M; Grenfeldt B; Davidsson P; Stridsberg M; Regland B; Gottfries C G; Blennow K
Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9(4):311-5.
1999: Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
Archives of neurology 1999;56(6):673-80.
1999: Hulstaert F; Blennow K; Ivanoiu A; Schoonderwaldt H C; Riemenschneider M; De Deyn P P; Bancher C; Cras P; Wiltfang J; Mehta P D; Iqbal K; Pottel H; Vanmechelen E; Vanderstichele H
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.
Neurology 1999;52(8):1555-62.
1999: Nilsson C L; Puchades M; Westman A; Blennow K; Davidsson P
Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry.
Electrophoresis 1999;20(4-5):860-5.
1999: Davidsson P; Puchades M; Blennow K
Identification of synaptic vesicle, pre- and postsynaptic proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing.
Electrophoresis 1999;20(3):431-7.
1999: Rosengren L E; Karlsson J E; Sjögren M; Blennow K; Wallin A
Neurofilament protein levels in CSF are increased in dementia.
Neurology 1999;52(5):1090-3.
1999: Davidsson P; Westman A; Puchades M; Nilsson C L; Blennow K
Characterization of proteins from human cerebrospinal fluid by a combination of preparative two-dimensional liquid-phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Analytical chemistry 1999;71(3):642-7.
1999: Puchades M; Westman A; Blennow K; Davidsson P
Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis.
Rapid communications in mass spectrometry : RCM 1999;13(24):2450-5.
1999: Puchades M; Westman A; Blennow K; Davidsson P
Removal of sodium dodecyl sulfate from protein samples prior to matrix-assisted laser desorption/ionization mass spectrometry.
Rapid communications in mass spectrometry : RCM 1999;13(5):344-9.
1999: Andreasen N; Blennow K; Sjödin C; Winblad B; Svärdsudd K
Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project.
Neuroepidemiology 1999;18(3):144-55.
1998: Lidström A M; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Experimental neurology 1998;154(2):511-21.
1998: Skoog I; Marcusson J; Blennow K
Dementia. It's getting better all the time.
Lancet 1998;352 Suppl 4():SIV4.
1998: Sjögren M; Minthon L; Passant U; Blennow K; Wallin A
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
Neurobiology of aging 1998;19(5):379-84.
1998: Skoog I; Wallin A; Fredman P; Hesse C; Aevarsson O; Karlsson I; Gottfries C G; Blennow K
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
Neurology 1998;50(4):966-71.
1998: Davidsson P; Blennow K
Neurochemical dissection of synaptic pathology in Alzheimer's disease.
International psychogeriatrics / IPA 1998;10(1):11-23.
1998: Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
Journal of neurology, neurosurgery, and psychiatry 1998;64(3):298-305.
1998: Robertsson B; Blennow K; Gottfries C G; Wallin A
Delirium in dementia.
International journal of geriatric psychiatry 1998;13(1):49-56.
1998: Skoog I; Hesse C; Aevarsson O; Landahl S; Wahlström J; Fredman P; Blennow K
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality.
Journal of neurology, neurosurgery, and psychiatry 1998;64(1):37-43.
1998: Nilsson C; Westman A; Blennow K; Ekman R
Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry.
Peptides 1998;19(7):1137-46.
1998: Blennow K; Vanmechelen E
Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.
Journal of neural transmission. Supplementum 1998;53():223-35.
1997: Tarvonen-Schröder S; Blennow K; Lekman A; Fredman P; Räihä I; Sourander L
Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis.
Dementia and geriatric cognitive disorders 1997;8(3):174-9.
1997: Arranz B; Blennow K; Eriksson A; Månsson J E; Marcusson J
Serotonergic, noradrenergic, and dopaminergic measures in suicide brains.
Biological psychiatry 1997;41(10):1000-9.
1997: Minthon L; Hesse C; Sjögren M; Englund E; Gustafson L; Blennow K
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
Neuroscience letters 1997;226(1):65-7.
1997: Skoog I; Hesse C; Fredman P; Andreasson L A; Palmertz B; Blennow K
Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
Archives of neurology 1997;54(3):267-72.
1997: Augustinsson L E; Blennow K; Blomstrand C; Bråne G; Ekman R; Fredman P; Karlsson I; Kihlgren M; Lehmann W; Lekman A; Månsson J E; Ramström I; Wallin A; Wikkelsö C; Gottfries C G; Svennerholm L
Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients.
Dementia and geriatric cognitive disorders 1997;8(1):26-33.
1997: Davidsson P; Ekman R; Blennow K
A new procedure for detecting brain-specific proteins in cerebrospinal fluid.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(6-7):711-20.
1996: Wallin A; Edman A; Blennow K; Gottfries C G; Karlsson I; Regland B; Sjögren M
Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia.
Journal of geriatric psychiatry and neurology 1996;9(4):185-99.
1996: Landén M; Thorsell A; Wallin A; Blennow K
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1996;61(4):352-6.
1996: Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Dementia (Basel, Switzerland) 1996;7(5):273-8.
1996: Wallin A; Blennow K; Rosengren L E
Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.
Dementia (Basel, Switzerland) 1996;7(5):267-72.
1996: Blennow K; Davidsson P; Gottfries C G; Ekman R; Heilig M
Synaptic degeneration in thalamus in schizophrenia.
Lancet 1996;348(9028):692-3.
1996: Bayard-Burfield L; Alling C; Blennow K; Jönsson S; Träskman-Bendz L
Impairment of the blood-CSF barrier in suicide attempters.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6(3):195-9.
1996: Strömbom U; Krotkiewski M; Blennow K; Månsson J E; Ekman R; Björntorp P
The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(4):361-8.
1996: Davidsson P; Jahn R; Bergquist J; Ekman R; Blennow K
Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1996;27(2):195-210.
1996: Heilig M; Månsson J E; Blennow K
Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
Biological psychiatry 1996;39(4):299-301.
1996: Wallin A; Blennow K; Edman A; Månsson J E
Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia.
International psychogeriatrics / IPA 1996;8(3):425-36.
1996: Arranz B; Blennow K; Ekman R; Eriksson A; Månsson J E; Marcusson J
Brain monoaminergic and neuropeptidergic variations in human aging.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(1-2):101-15.
1996: Blennow K; Cowburn R F
The neurochemistry of Alzheimer's disease.
Acta neurologica Scandinavica. Supplementum 1996;168():77-86.
1996: Blennow K; Skoog I; Wallin A; Wikkelsö C; Fredman P
Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age.
European neurology 1996;36(4):201-5.
1996: Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(5):603-18.
1996: Wallin A; Blennow K
Clinical subgroups of the Alzheimer syndrome.
Acta neurologica Scandinavica. Supplementum 1996;165():51-7.
1996: Nilsson C; Karlsson G; Blennow K; Heilig M; Ekman R
Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients.
Peptides 1996;17(3):359-62.
1995: Skoog I; Vanmechelen E; Andreasson L A; Palmertz B; Davidsson P; Hesse C; Blennow K
A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(4):433-42.
1995: Blennow K; Wallin A; Agren H; Spenger C; Siegfried J; Vanmechelen E
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1995;26(3):231-45.
1995: Karlsson J O; Blennow K; Janson I; Blomgren K; Karlsson I; Regland B; Wallin A; Gottfries C G
Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease.
Neurobiology of aging 1995;16(6):901-6.
1995: Blennow K; Davidsson P; Wallin A; Ekman R
Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?
Dementia (Basel, Switzerland) 1995;6(6):306-11.
1995: Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
Biological psychiatry 1995;38(4):210-6.
1995: Blennow K; Wallin A; Chong J K
Cerebrospinal fluid 'neuronal thread protein' comes from serum by passage over the blood-brain barrier.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(2):187-93.
1995: Gottfries J; Blennow K; Wallin A; Gottfries C G
Diagnosis of dementias using partial least squares discriminant analysis.
Dementia (Basel, Switzerland) 1995;6(2):83-8.
1995: Blennow K; Fredman P
Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystem.
Acta neurochirurgica 1995;136(3-4):135-9.
1994: Josefsson E; Månsson J E; Blennow K; Tarkowski A
Immunomodulating and anti-inflammatory properties of the sympatholytic compound 6-hydroxydopamine.
Journal of neuroimmunology 1994;55(2):161-9.
1994: Blennow K; Hesse C; Fredman P
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
Neuroreport 1994;5(18):2534-6.
1994: Gottfries C G; Balldin J; Blennow K; Bråne G; Karlsson I; Regland B; Wallin A
Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.
Annals of the New York Academy of Sciences 1994;746():336-43; discussion 343-4.
1994: Balldin J; Blennow K; Bråne G; Gottfries C G; Karlsson I; Regland B; Wallin A
Relationship between mental impairment and HPA axis activity in dementia disorders.
Dementia (Basel, Switzerland) 1994;5(5):252-6.
1994: Wallin A; Blennow K
The clinical diagnosis of vascular dementia.
Dementia (Basel, Switzerland) 1994;5(3-4):181-4.
1994: Gottfries C G; Blennow K; Karlsson I; Wallin A
The neurochemistry of vascular dementia.
Dementia (Basel, Switzerland) 1994;5(3-4):163-7.
1994: Mattila K M; Pirttilä T; Blennow K; Wallin A; Viitanen M; Frey H
Altered blood-brain-barrier function in Alzheimer's disease?
Acta neurologica Scandinavica 1994;89(3):192-8.
1994: Blennow K; Fredman P; Wallin A; Gottfries C G; Frey H; Pirttilä T; Skoog I; Wikkelsö C; Svennerholm L
Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis.
Journal of the neurological sciences 1994;121(1):90-6.
1994: Blennow K; Davidsson P; Wallin A; Gottfries C G; Svennerholm L
Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.
International psychogeriatrics / IPA 1994;6(1):13-22; discussion 59-60.
1994: Gottfries C G; Balldin J; Blennow K; Bråne G; Karlsson I; Regland B; Wallin A
Hypothalamic dysfunction in dementia.
Journal of neural transmission. Supplementum 1994;43():203-9.
1994: Blennow K; Wallin A; Ekman R
Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(3):183-91.
1993: Blennow K; Wallin A; Häger O
Low frequency of post-lumbar puncture headache in demented patients.
Acta neurologica Scandinavica 1993;88(3):221-3.
1993: Wallin A; Blennow K
Heterogeneity of vascular dementia: mechanisms and subgroups.
Journal of geriatric psychiatry and neurology 1993;6(3):177-88.
1993: Landin K; Blennow K; Wallin A; Gottfries C G
Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?
Journal of internal medicine 1993;233(4):357-63.
1993: Wallin A; Blennow K
[The concept of dementia--does it enlighten or confuse?]
Läkartidningen 1993;90(13):1235-6.
1993: Blennow K; Wallin A; Gottfries C G; Karlsson I; Månsson J E; Skoog I; Wikkelsö C; Svennerholm L
Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):55-61.
1993: Blennow K; Fredman P; Wallin A; Gottfries C G; Skoog I; Wikkelsö C; Svennerholm L
Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production.
European neurology 1993;33(2):134-42.
1993: Blennow K; Fredman P; Wallin A; Gottfries C G; Karlsson I; Långström G; Skoog I; Svennerholm L; Wikkelsö C
Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.
European neurology 1993;33(2):129-33.
1993: Blennow K; Fredman P; Wallin A; Gottfries C G; Långström G; Svennerholm L
Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.
European neurology 1993;33(2):126-8.
1993: Blennow K; Wallin A; Gottfries C G; Månsson J E; Svennerholm L
Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Journal of neural transmission. Parkinson's disease and dementia section 1993;5(1):5-15.
1992: Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries C G; Månsson J E; Svennerholm L
Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
Aging (Milan, Italy) 1992;4(4):301-6.
1992: Blennow K; Wallin A
Clinical heterogeneity of probable Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1992;5(2):106-13.
1992: Regland B; Abrahamsson L; Blennow K; Gottfries C G; Wallin A
Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men.
Acta neurologica Scandinavica 1992;85(4):276-81.
1992: Fredman P; Wallin A; Blennow K; Davidsson P; Gottfries C G; Svennerholm L
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia.
Acta neurologica Scandinavica 1992;85(2):103-6.
1992: Blennow K; Wallin A; Gottfries C G; Lekman A; Karlsson I; Skoog I; Svennerholm L
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
Neurobiology of aging 1992;13(1):107-13.
1992: Wallin A; Blennow K
Clinical diagnosis of Alzheimer's disease by primary care physicians and specialists.
Acta neurologica Scandinavica. Supplementum 1992;139():26-31.
1991: Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries C G; Karlsson I; Månsson J E; Svennerholm L
Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.
Archives of neurology 1991;48(10):1032-5.
1991: Blennow K; Wallin A; Uhlemann C; Gottfries C G
White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors.
Acta neurologica Scandinavica 1991;83(3):187-93.
1991: Prior R; Mönning U; Schreiter-Gasser U; Weidemann A; Blennow K; Gottfries C G; Masters C L; Beyreuther K
Quantitative changes in the amyloid beta A4 precursor protein in Alzheimer cerebrospinal fluid.
Neuroscience letters 1991;124(1):69-73.
1991: Wallin A; Blennow K
Pathogenetic basis of vascular dementia.
Alzheimer disease and associated disorders 1991;5(2):91-102.
1990: Blennow K; Wallin A; Gottfries C G
Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease.
Aging (Milan, Italy) 1990;2(4):395-401.
1990: Blennow K; Wallin A; Fredman P; Gottfries C G; Karlsson I; Svennerholm L
Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1990;1(1):79-81.
1990: Nilsson E; Alafuzoff I; Blennow K; Blomgren K; Hall C M; Janson I; Karlsson I; Wallin A; Gottfries C G; Karlsson J O
Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue.
Neurobiology of aging 1990;11(4):425-31.
1990: Blennow K; Wallin A; Fredman P; Karlsson I; Gottfries C G; Svennerholm L
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.
Acta neurologica Scandinavica 1990;81(4):323-6.
1990: Wallin A; Blennow K; Fredman P; Gottfries C G; Karlsson I; Svennerholm L
Blood brain barrier function in vascular dementia.
Acta neurologica Scandinavica 1990;81(4):318-22.
1990: Wallin A; Blennow K; Fredman P; Gottfries C G; Karlsson I; Svennerholm L
Intrathecal synthesis of immunoglobulin G in vascular dementia.
Acta neurologica Scandinavica 1990;81(2):168-72.
1990: Svennerholm L; Gottfries C G; Blennow K; Fredman P; Karlsson I; Månsson J E; Toffano G; Wallin A
Parenteral administration of GM1 ganglioside to presenile Alzheimer patients.
Acta neurologica Scandinavica 1990;81(1):48-53.
1990: Blennow K; Wallin A; Davidsson P; Fredman P; Gottfries C G; Svennerholm L
Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.
Alzheimer disease and associated disorders 1990;4(2):79-86.
1989: Wallin A; Blennow K; Uhlemann C; Långström G; Gottfries C G
White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia--diagnostic and pathogenetic aspects.
Acta neurologica Scandinavica 1989;80(6):518-23.
1989: Bråne G; Gottfries C G; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Alzheimer disease and associated disorders 1989;3(3):148-56.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Kaj Blennow

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Procedures

Phenomena

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Kaj Blennow (preview)

All Publications